Patient¿s weight was not provided.The heartmate 3 lvas was implanted during the momentum 3 clinical trial, ide# (b)(4).Fda approval for heartmate 3 lvas was received on 23 august 2017.The same device is used commercially and in the ongoing momentum 3 long term trial.The gtin unique device identifier for the commercial heartmate3 modular cable is (b)(4).Approximate age of device ¿ 1 year and 7 months.The device was returned for investigation.The evaluation is not yet complete.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
|